NGS Sample Preparation Market Updates

NGS Sample Preparation Market size was valued at USD 1.84 Billion in 2023 and is poised to grow from USD 2.1 Billion in 2024 to USD 6.14 Billion by 2032, growing at a CAGR of 14.32% during the forecast period (2025-2032).

The global NGS sample preparation market is highly competitive and dynamic, driven by the increasing adoption of NGS technology across various applications, including genomics, transcriptomics, and epigenomics. The market is characterized by a diverse range of players, including both established companies and emerging startups, all striving to capture a share in this rapidly expanding market. 'Illumina, Inc. ', 'Thermo Fisher Scientific Inc. ', 'F. Hoffmann-La Roche Ltd. ', 'Revvity Inc. ', 'Agilent Technologies, Inc. ', 'Danaher ', 'Becton, Dickinson and Company ', 'Qiagen ', 'Merck KGaA ', 'Bio-Rad Laboratories, Inc. ', 'Promega Corporation ', 'Eurofins Scientific ', 'BGI Group ', '10x Genomics ', 'Sysmex Corporation ', 'Psomagen ', 'Zymo Research Corporation ', 'Takara Holdings Inc ', 'Nanjing Novogene Bio Technology Co., Ltd. ', 'New England Biolabs'

NGS sample preparation plays a vital role in various genomic research applications, such as gene expression analysis, variant detection, biomarker discovery, and metagenomics. As the field of genomics continues to expand, the demand for efficient and high-throughput sample preparation methods for NGS grows significantly.

A significant market trend in the global Next-Generation Sequencing (NGS) sample preparation market is the increasing adoption of automated and high-throughput sample preparation solutions. This trend is driven by the growing demand for efficient and streamlined processes to handle the rising volume of samples in NGS workflows. Automated sample preparation systems offer several advantages such as reduced manual labor, improved reproducibility, enhanced accuracy, and increased sample throughput. These systems utilize advanced robotics and liquid handling technologies to automate various steps in the sample preparation process, including DNA/RNA extraction, library preparation, and target enrichment.

North America dominated the global NGS (Next-Generation Sequencing) sample preparation market. North America, comprising countries such as the US and Canada, holds a significant share in the market. The region has a well-established healthcare infrastructure, a strong presence of key market players, and a high adoption rate of advanced genomic technologies. Additionally, extensive research and development activities in genomics and personalized medicine contribute to the dominance of North America in the NGS sample preparation market.